ArticleInnovation (Cambridge (Mass.))2022

Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial.

Zhihao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.